Frost & Sullivan’s recent analysis, Smartphone-based Saliva Testing and Self-monitoring of Blood Glucose Driving the Digital POCT Market, finds that adoption of digital point-of-care testing (POCT) is gaining momentum, according to a company news release.
“More people are opting for self-monitoring for the rapid screening of respiratory diseases and saliva sample-based testing. The COVID-19 outbreak and increase in diabetes patients give further impetus to the digital POCT market, addressing remote diagnostics needs. The dawn of 5G with machine-based intelligence, data analytics, and the internet of things (IoT) promises new ways to personalize diagnostic testing while reducing hospital visits and medical costs,” Frost & Sullivan said.
The company notes the following trends in home-based testing in the report:
· The growing importance of rapid testing and contact tracing for COVID-19 has fueled interest in at-home tests, particularly smartphone-read lateral flow antigen tests, which “are game-changers powering the testing ecosystem to overcome the demand for rapid testing.”
· Digital diabetes monitoring to measure blood glucose levels via mobile apps using a smartphone camera and test strips eliminates the need for blood glucose meters.
